165 related articles for article (PubMed ID: 20805790)
1. Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis.
Zecchin KG; Rossato FA; Raposo HF; Melo DR; Alberici LC; Oliveira HC; Castilho RF; Coletta RD; Vercesi AE; Graner E
Lab Invest; 2011 Feb; 91(2):232-40. PubMed ID: 20805790
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid synthase inhibitors induce apoptosis in non-tumorigenic melan-a cells associated with inhibition of mitochondrial respiration.
Rossato FA; Zecchin KG; La Guardia PG; Ortega RM; Alberici LC; Costa RA; Catharino RR; Graner E; Castilho RF; Vercesi AE
PLoS One; 2014; 9(6):e101060. PubMed ID: 24964211
[TBL] [Abstract][Full Text] [Related]
3. Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model.
Bastos DC; Paupert J; Maillard C; Seguin F; Carvalho MA; Agostini M; Coletta RD; Noël A; Graner E
Lab Invest; 2017 Feb; 97(2):194-206. PubMed ID: 27918556
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model.
Carvalho MA; Zecchin KG; Seguin F; Bastos DC; Agostini M; Rangel AL; Veiga SS; Raposo HF; Oliveira HC; Loda M; Coletta RD; Graner E
Int J Cancer; 2008 Dec; 123(11):2557-65. PubMed ID: 18770866
[TBL] [Abstract][Full Text] [Related]
5. The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas.
Seguin F; Carvalho MA; Bastos DC; Agostini M; Zecchin KG; Alvarez-Flores MP; Chudzinski-Tavassi AM; Coletta RD; Graner E
Br J Cancer; 2012 Sep; 107(6):977-87. PubMed ID: 22892389
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis.
Grube S; Dünisch P; Freitag D; Klausnitzer M; Sakr Y; Walter J; Kalff R; Ewald C
J Neurooncol; 2014 Jun; 118(2):277-287. PubMed ID: 24789255
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic and toxicologic evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells.
Deepa PR; Vandhana S; Jayanthi U; Krishnakumar S
Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):494-503. PubMed ID: 22151915
[TBL] [Abstract][Full Text] [Related]
8. Visualizing inhibition of fatty acid synthase through mass spectrometric analysis of mitochondria from melanoma cells.
Zecchin KG; Alberici LC; Riccio MF; Eberlin MN; Vercesi AE; Graner E; Catharino RR
Rapid Commun Mass Spectrom; 2011 Feb; 25(3):449-52. PubMed ID: 21213365
[TBL] [Abstract][Full Text] [Related]
9. The antimetastatic activity of orlistat is accompanied by an antitumoral immune response in mouse melanoma.
de Almeida LY; Mariano FS; Bastos DC; Cavassani KA; Raphelson J; Mariano VS; Agostini M; Moreira FS; Coletta RD; Mattos-Graner RO; Graner E
Cancer Chemother Pharmacol; 2020 Feb; 85(2):321-330. PubMed ID: 31863126
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells.
Ho TS; Ho YP; Wong WY; Chi-Ming Chiu L; Wong YS; Eng-Choon Ooi V
Biomed Pharmacother; 2007 Oct; 61(9):578-87. PubMed ID: 17904792
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: role of cell survival regulatory molecules.
Kant S; Kumar A; Singh SM
Biochim Biophys Acta; 2012 Nov; 1820(11):1764-73. PubMed ID: 22877747
[TBL] [Abstract][Full Text] [Related]
12. Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype.
Kant S; Kumar A; Singh SM
Biochim Biophys Acta; 2014 Jan; 1840(1):294-302. PubMed ID: 24060750
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholine.
Ross J; Najjar AM; Sankaranarayanapillai M; Tong WP; Kaluarachchi K; Ronen SM
Mol Cancer Ther; 2008 Aug; 7(8):2556-65. PubMed ID: 18723500
[TBL] [Abstract][Full Text] [Related]
14. Development of a Self-Assembled Nanoparticle Formulation of Orlistat, Nano-ORL, with Increased Cytotoxicity against Human Tumor Cell Lines.
Hill TK; Davis AL; Wheeler FB; Kelkar SS; Freund EC; Lowther WT; Kridel SJ; Mohs AM
Mol Pharm; 2016 Mar; 13(3):720-8. PubMed ID: 26824142
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid synthase inhibition induces differential expression of genes involved in apoptosis and cell proliferation in ocular cancer cells.
Deepa PR; Vandhana S; Krishnakumar S
Nutr Cancer; 2013; 65(2):311-6. PubMed ID: 23441619
[TBL] [Abstract][Full Text] [Related]
16. FASN Inhibitors Enhance Bestatin-Related Tumor Cell Apoptosis Through Upregulating PEPT1.
Ni J; Shang Y; Wang WD; Wang C; Wang AM; Li GJ; Chen SZ
Curr Mol Pharmacol; 2023; 16(7):771-786. PubMed ID: 36411574
[TBL] [Abstract][Full Text] [Related]
17. Blockade of fatty acid synthase triggers significant apoptosis in mantle cell lymphoma.
Gelebart P; Zak Z; Anand M; Belch A; Lai R
PLoS One; 2012; 7(4):e33738. PubMed ID: 22485149
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis.
Lee KH; Lee MS; Cha EY; Sul JY; Lee JS; Kim JS; Park JB; Kim JY
Mol Med Rep; 2017 Apr; 15(4):2163-2173. PubMed ID: 28260110
[TBL] [Abstract][Full Text] [Related]
19. Metabolic shifts induced by fatty acid synthase inhibitor orlistat in non-small cell lung carcinoma cells provide novel pharmacodynamic biomarkers for positron emission tomography and magnetic resonance spectroscopy.
Sankaranarayanapillai M; Zhang N; Baggerly KA; Gelovani JG
Mol Imaging Biol; 2013 Apr; 15(2):136-47. PubMed ID: 22886728
[TBL] [Abstract][Full Text] [Related]
20. Dietary soy protein inhibits DNA damage and cell survival of colon epithelial cells through attenuated expression of fatty acid synthase.
Xiao R; Su Y; Simmen RC; Simmen FA
Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G868-76. PubMed ID: 18239060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]